Another example demonstrating the importance of considering genetic status is the analysis of certain mutations that occur in the early stages of CRC such as Kirsten rat sarcoma (KRAS) and proto-oncogene B-Raf (BRAF) mutations. The gene discussed is BRAF; the disease is colorectal carcinoma.